Literature DB >> 18455397

Australian breast cancer specialists' involvement in multidisciplinary treatment planning meetings.

James D Harrison1, Ellis T Choy, Andrew Spillane, Phyllis Butow, Jane M Young, Alison Evans.   

Abstract

Australian breast cancer specialists' involvement in multidisciplinary team (MDT) treatment planning meetings was ascertained in a cross sectional survey. The format of MDT meetings was also investigated. Medical specialists were regular attendees (>or=78%) compared to allied health staff and psychologists (<or=28%). Clinicians based in a major city (AOR 1.90; 95%CI: 1.01-3.58) and who treated >or=50 new cases a year (AOR 7.34; 95%CI: 3.38-15.96) were more likely to attend. Over 69% reported that the proportion of time devoted to case discussions was >or=75%. Topics always discussed were pathology, extent of disease, surgery performed and a treatment plan (>or=83%). The majority of respondents stated that MDT meetings were effective and improved referrals. Suggested improvements included that all key personnel attend, meetings are structured and that the views of all be heard. Work is needed to ensure MDT's function and co-operate as intended in treatment planning meetings.

Entities:  

Mesh:

Year:  2008        PMID: 18455397     DOI: 10.1016/j.breast.2008.03.001

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  8 in total

Review 1.  Multidisciplinary care of breast cancer patients: a scoping review of multidisciplinary styles, processes, and outcomes.

Authors:  J Shao; M Rodrigues; A L Corter; N N Baxter
Journal:  Curr Oncol       Date:  2019-06-01       Impact factor: 3.677

2.  Does multidisciplinary care enhance the management of advanced breast cancer?: evaluation of advanced breast cancer multidisciplinary team meetings.

Authors:  Jacquie Chirgwin; Melinda Craike; Christine Gray; Kathy Watty; Linda Mileshkin; Patricia M Livingston
Journal:  J Oncol Pract       Date:  2010-11       Impact factor: 3.840

3.  Decision-Making in Multidisciplinary Tumor Boards in Breast Cancer Care - An Observational Study.

Authors:  Barbara Schellenberger; Annika Diekmann; Christian Heuser; Nikoloz Gambashidze; Nicole Ernstmann; Lena Ansmann
Journal:  J Multidiscip Healthc       Date:  2021-06-01

4.  Evaluation of the impact of interdisciplinarity in cancer care.

Authors:  Dominique Tremblay; Danièle Roberge; Linda Cazale; Nassera Touati; Elizabeth Maunsell; Jean Latreille; Jacques Lemaire
Journal:  BMC Health Serv Res       Date:  2011-06-03       Impact factor: 2.655

5.  Multidisciplinary team approach in breast cancer: a nationwide survey in Korea.

Authors:  Byung Joo Chae; Ja Seong Bae; Byung Joo Song; Sang Seol Jung
Journal:  J Korean Surg Soc       Date:  2012-05-29

6.  Patient Participation in Multidisciplinary Tumor Conferences from the Providers' Perspective: Is It Feasible in Routine Cancer Care?

Authors:  Christian Heuser; Annika Diekmann; Barbara Schellenberger; Barbara Bohmeier; Walther Kuhn; Ute Karbach; Nicole Ernstmann; Lena Ansmann
Journal:  J Multidiscip Healthc       Date:  2020-11-27

7.  2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.

Authors:  Keith C Bible; Electron Kebebew; James Brierley; Juan P Brito; Maria E Cabanillas; Thomas J Clark; Antonio Di Cristofano; Robert Foote; Thomas Giordano; Jan Kasperbauer; Kate Newbold; Yuri E Nikiforov; Gregory Randolph; M Sara Rosenthal; Anna M Sawka; Manisha Shah; Ashok Shaha; Robert Smallridge; Carol K Wong-Clark
Journal:  Thyroid       Date:  2021-03       Impact factor: 6.568

8.  Determinants of treatment plan implementation in multidisciplinary team meetings for patients with chronic diseases: a mixed-methods study.

Authors:  Rosalind Raine; Penny Xanthopoulou; Isla Wallace; Caoimhe Nic A' Bháird; Anne Lanceley; Alex Clarke; Gill Livingston; Archie Prentice; Dave Ardron; Miriam Harris; Michael King; Susan Michie; Jane M Blazeby; Natalie Austin-Parsons; Simon Gibbs; Julie Barber
Journal:  BMJ Qual Saf       Date:  2014-06-09       Impact factor: 7.035

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.